Novel sex-biased outcomes in neuroblastoma are associated with distinct gene expression and chromosomal loss patterns
Preprint
Abstract
The worst patient outcomes in neuroblastoma are driven by high-risk disease 1,2 , which is divided into similarly sized MYCN amplified and MYCN non-amplified patient subgroups 3 . Male patients have been reported to have slightly worse outcomes than females in all-patient analyses of multiple studies 3,4 . However, we show here that in MYCN non- amplified high-risk and stage 4s low-risk disease, female patients have significantly worse overall survival than males. Female MYCN non-amplified high-risk patients highly express H19 and DLK1 , both of which drive cell growth in vitro and are associated with worse outcomes in females but not males. Further, chromosome-specific expression analysis of these patients reveals broad sex disparities in chromosomal patterning, including female-specific retention of chromosome 11q, a pattern typically reserved for MYCN -amplified disease 5,6 . Finally, we show that H19 , a known let-7 microRNA target 7 , sequesters let-7 in females, providing a rationale for worse female survival and reconciling retention of chromosome 11q. We propose that this novel sex-based outcome disparity is driven by let-7 inhibition, expanding on a model of neuroblastoma development where let-7 mitigation is central to disease pathology 8 .Keywords
This publication has 51 references indexed in Scilit:
- A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019Pediatric Blood & Cancer, 2023
- Cancer‐specific survival after diagnosis in men versus women: A pan‐cancer analysisMedcomm, 2022
- Distribution of segmental chromosomal alterations in neuroblastomaClinical and Translational Oncology, 2020
- An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importanceMolecular Biology Reports, 2020
- Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive diseasePediatric Blood & Cancer, 2019
- The long non-coding RNA H19: an active player with multiple facets to sustain the hallmarks of cancerCellular and Molecular Life Sciences, 2019
- Analysis of the Paternally-Imprinted DLK1–MEG3 and IGF2–H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic TargetStem Cell Reviews and Reports, 2018
- Allelic deletion at chromosome bands 11q14-23 is common in neuroblastomaMedical and Pediatric Oncology, 2001
- Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locusHuman Genetics, 1996
- Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGPCancer Genetics and Cytogenetics, 1995